Among them, let-17b that was downregulated in plasma of CTEPH patients has been shown to directly target endothelin-1 (ET-1) and cause dysfunction of pulmonary arterial endothelial cells [53]. This evidence concerns the gene EDN1 and chronic thromboembolic pulmonary hypertension.